Catalyst Funds Management Pty Ltd Takes $223,000 Position in Grail, Inc. (NASDAQ:GRAL)

Catalyst Funds Management Pty Ltd bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 12,500 shares of the company’s stock, valued at approximately $223,000.

Several other large investors also recently modified their holdings of the business. Crcm LP acquired a new stake in shares of Grail during the fourth quarter valued at about $65,061,000. Bank of New York Mellon Corp acquired a new stake in shares of Grail during the fourth quarter valued at about $6,262,000. TCW Group Inc. acquired a new stake in shares of Grail during the fourth quarter valued at about $5,095,000. abrdn plc acquired a new stake in shares of Grail during the fourth quarter valued at about $3,768,000. Finally, Commonwealth Equity Services LLC acquired a new position in Grail in the fourth quarter worth about $3,278,000.

Grail Trading Up 10.5 %

NASDAQ:GRAL opened at $29.74 on Monday. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99. The stock has a 50-day simple moving average of $31.81 and a 200 day simple moving average of $21.39.

Grail (NASDAQ:GRAL) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Equities research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Grail

In other Grail news, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now directly owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares of the company’s stock, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,550 shares of company stock worth $360,436 over the last ninety days.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley began coverage on Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.